{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T10:00:25Z","timestamp":1794304825074,"version":"4.9.0"},"reference-count":178,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670895"],"award-info":[{"award-number":["81670895"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700841"],"award-info":[{"award-number":["81700841"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970839"],"award-info":[{"award-number":["81970839"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["2016FZ0091"],"award-info":[{"award-number":["2016FZ0091"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["21ZDYF0551"],"award-info":[{"award-number":["21ZDYF0551"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.gendis.2021.02.009","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T11:36:13Z","timestamp":1614425773000},"page":"62-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":397,"title":["Age-related macular degeneration: Epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy"],"prefix":"10.1016","volume":"9","author":[{"given":"Yanhui","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifeng","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9803-2558","authenticated-orcid":false,"given":"Mingyan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.gendis.2021.02.009_bib1","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1001\/archopht.123.11.1484","article-title":"The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17","volume":"123","author":"Davis","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"10.1016\/j.gendis.2021.02.009_bib2","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1001\/archopht.123.11.1570","article-title":"A simplified severity scale for age-related macular degeneration: AREDS Report No. 18","volume":"123","author":"Ferris","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"9827","key":"10.1016\/j.gendis.2021.02.009_bib3","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","article-title":"Age-related macular degeneration","volume":"379","author":"Lim","year":"2012","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.gendis.2021.02.009_bib4","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.ophtha.2016.05.043","article-title":"Validating the AREDS simplified severity scale of age-related macular degeneration with 5- and 10-year incident data in a population-based sample","volume":"123","author":"Liew","year":"2016","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.gendis.2021.02.009_bib5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1056\/NEJM200002173420707","article-title":"Age-related macular degeneration","volume":"342","author":"Fine","year":"2000","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gendis.2021.02.009_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.preteyeres.2009.10.001","article-title":"Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease?","volume":"29","author":"Laude","year":"2010","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"10.1016\/j.gendis.2021.02.009_bib7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/jamaophthalmol.2016.0588","article-title":"Prevalence of age-related macular degeneration in Chinese American adults: the Chinese American eye study","volume":"134","author":"Varma","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.gendis.2021.02.009_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/IAE.0000000000001556","article-title":"Angiographic subtypes of polypoidal choroidal vasculopathy in taniwan: a prospective multicenter study","volume":"38","author":"Yeung","year":"2018","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.gendis.2021.02.009_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2214-109X(13)70163-3","article-title":"Global prevalence of age-related macular degeneration","volume":"2","author":"Jonas","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"2","key":"10.1016\/j.gendis.2021.02.009_bib10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"5","key":"10.1016\/j.gendis.2021.02.009_bib11","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.ophtha.2009.10.007","article-title":"The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis","volume":"117","author":"Kawasaki","year":"2010","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.gendis.2021.02.009_bib12","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archopht.1941.00870100042005","article-title":"Prevalence of age-related macular degeneration in the United States","volume":"122","author":"Friedman","year":"2004","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.gendis.2021.02.009_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ophtha.2005.12.013","article-title":"Prevalence of age-related macular degeneration in 4 racial\/ethnic groups in the multi ethnic study of atherosclerosis","volume":"113","author":"Klein","year":"2006","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.gendis.2021.02.009_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archophthalmol.2010.318","article-title":"Prevalence of age-related macular degeneration in the US population","volume":"129","author":"Klein","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.gendis.2021.02.009_bib15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ajo.2015.09.031","article-title":"Geo-Epidemiology of age-related macular degeneration: new clues into the pathogenesis","volume":"161","author":"Reibaldi","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.gendis.2021.02.009_bib16","article-title":"The national and subnational prevalence and burden of age-related macular degeneration in China","volume":"7","author":"Song","year":"2017","journal-title":"J Glob Health"},{"issue":"1","key":"10.1016\/j.gendis.2021.02.009_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2415-10-31","article-title":"Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis","volume":"10","author":"Chakravarthy","year":"2010","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"10.1016\/j.gendis.2021.02.009_bib18","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.survophthal.2015.10.003","article-title":"Association of age-related macular degeneration and reticular macular disease with cardiovascular disease","volume":"61","author":"Rastogi","year":"2016","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"10.1016\/j.gendis.2021.02.009_bib19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ajo.2011.02.025","article-title":"Risk factors for four-year incidence and progression of age-related macular degeneration: the los angeles latino eye study","volume":"152","author":"Choudhury","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.gendis.2021.02.009_bib20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1556\/OH.2015.30017","article-title":"The age-related macular degeneration as a vascular disease\/part of systemic vasculopathy: contributions to its pathogenesis","volume":"156","author":"Fischer","year":"2015","journal-title":"Orv Hetil"},{"issue":"8","key":"10.1016\/j.gendis.2021.02.009_bib21","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/eye.2017.47","article-title":"Age-related macular degeneration in a South Indian population, with and without diabetes","volume":"31","author":"Srinivasan","year":"2017","journal-title":"Eye (Lond)."},{"issue":"2","key":"10.1016\/j.gendis.2021.02.009_bib22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/archophthalmol.2010.355","article-title":"Diabetes mellitus and early age-related macular degeneration","volume":"129","author":"Choi","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.gendis.2021.02.009_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archophthalmol.2008.551","article-title":"Serum cystatin C level, kidney disease markers, and incidence of age-related macular degeneration: the Beaver Dam Eye Study","volume":"127","author":"Klein","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.gendis.2021.02.009_bib24","first-page":"826","article-title":"Smoking and age-related macular degeneration","volume":"63","author":"Houston","year":"2001","journal-title":"Am Fam Phys"},{"issue":"12","key":"10.1016\/j.gendis.2021.02.009_bib25","doi-asserted-by":"crossref","first-page":"722","DOI":"10.4103\/0301-4738.120218","article-title":"Dietary and lifestyle risk factors associated with age-related macular degeneration: a hospital based study","volume":"61","author":"Bhatiwada","year":"2013","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"10.1016\/j.gendis.2021.02.009_bib26","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ajo.2007.12.005","article-title":"Alcohol consumption and the risk of age-related macular degeneration: a systematic review and meta-analysis","volume":"145","author":"Chong","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.gendis.2021.02.009_bib27","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1021\/jf026073e","article-title":"Distribution of lutein, zeaxanthin, and related geometrical isomers in fruit, vegetables, wheat, and pasta products","volume":"51","author":"Humphries","year":"2003","journal-title":"J Agric Food Chem"},{"issue":"11","key":"10.1016\/j.gendis.2021.02.009_bib28","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1167\/iovs.17-21673","article-title":"Associations between vitamin D intake and progression to incident advanced age-related macular degeneration","volume":"58","author":"Merle","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.gendis.2021.02.009_bib29","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3390\/nu8110743","article-title":"Fish consumption and age-related macular degeneration incidence: a meta-analysis and systematic review of prospective cohort studies","volume":"8","author":"Zhu","year":"2016","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.gendis.2021.02.009_bib30","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.mam.2012.03.005","article-title":"Nutritional modulation of age-related macular degeneration","volume":"33","author":"Weikel","year":"2012","journal-title":"Mol Aspects Med"},{"issue":"12","key":"10.1016\/j.gendis.2021.02.009_bib31","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.ophtha.2010.03.058","article-title":"The impact of fish and shellfish consumption on age-related macular degeneration","volume":"117","author":"Swenor","year":"2010","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.gendis.2021.02.009_bib32","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1136\/bjo.2008.143412","article-title":"Does eating particular diets alter the risk of age-related macular degeneration in users of the Age-Related Eye Disease Study supplements?","volume":"93","author":"Chiu","year":"2009","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.gendis.2021.02.009_bib33","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1167\/iovs.14-13916","article-title":"Circulating omega-3 Fatty acids and neovascular age-related macular degeneration","volume":"55","author":"Merle","year":"2014","journal-title":"Invest Ophthalmol"},{"issue":"5\u20136","key":"10.1016\/j.gendis.2021.02.009_bib34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/09286586.2018.1512634","article-title":"Risk factors for age-related macular degeneration in a Greek population: the thessaloniki eye study","volume":"25","author":"Anastasopoulos","year":"2018","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.gendis.2021.02.009_bib35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev-genom-090413-025610","article-title":"Age-related macular degeneration: genetics and biology coming together","volume":"15","author":"Fritsche","year":"2014","journal-title":"Annu Rev Genom Hum Genet"},{"issue":"5720","key":"10.1016\/j.gendis.2021.02.009_bib36","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"issue":"5720","key":"10.1016\/j.gendis.2021.02.009_bib37","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.1110359","article-title":"Complement factor H variant increases the risk of age-related macular degeneration","volume":"308","author":"Haines","year":"2005","journal-title":"Science"},{"issue":"5720","key":"10.1016\/j.gendis.2021.02.009_bib38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1110189","article-title":"Complement factor H polymorphism and age-related macular degeneration","volume":"308","author":"Edwards","year":"2005","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.gendis.2021.02.009_bib39","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1167\/iovs.05-1143","article-title":"Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers","volume":"47","author":"Sepp","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.gendis.2021.02.009_bib40","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jama.296.3.301","article-title":"Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration","volume":"296","author":"Despriet","year":"2006","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.gendis.2021.02.009_bib41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1167\/iovs.09-4135","article-title":"The involvement of complement factor B and complement component C2 in an Indian cohort with age-related macular degeneration","volume":"51","author":"Kaur","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.gendis.2021.02.009_bib42","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1006\/exer.2001.1094","article-title":"Complement activation and inflammatory processes in Drusen formation and age-related macular degeneration","volume":"73","author":"Johnson","year":"2001","journal-title":"Exp Eye Res"},{"issue":"7","key":"10.1016\/j.gendis.2021.02.009_bib43","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1073\/pnas.0408835103","article-title":"Drusen complement components C3a and C5a promote choroidal neovascularization","volume":"103","author":"Nozaki","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.gendis.2021.02.009_bib44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ejhg.2009.113","article-title":"Support for the involvement of complement factor I in age-related macular degeneration","volume":"18","author":"Ennis","year":"2010","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"10.1016\/j.gendis.2021.02.009_bib45","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.ophtha.2007.10.032","article-title":"Alleles in the HtrA serine peptidase 1 gene alter the risk of neovascular age-related macular degeneration","volume":"115","author":"Deangelis","year":"2008","journal-title":"Ophthalmology"},{"issue":"5801","key":"10.1016\/j.gendis.2021.02.009_bib46","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1126\/science.1133807","article-title":"HTRA1 promoter polymorphism in wet age-related macular degeneration","volume":"314","author":"Dewan","year":"2006","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.gendis.2021.02.009_bib47","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/ng.170","article-title":"Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA","volume":"40","author":"Fritsche","year":"2008","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.gendis.2021.02.009_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040355","article-title":"Neovascular age-related macular degeneration risk based on CFH, LOC387715\/HTRA1, and smoking","volume":"4","author":"Hughes","year":"2007","journal-title":"PLoS Med"},{"issue":"21","key":"10.1016\/j.gendis.2021.02.009_bib49","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/hmg\/ddi353","article-title":"Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk","volume":"14","author":"Rivera","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.gendis.2021.02.009_bib50","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1086\/503822","article-title":"Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration","volume":"78","author":"Schmidt","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"16","key":"10.1016\/j.gendis.2021.02.009_bib51","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/jama.297.16.1793","article-title":"Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration","volume":"297","author":"Seddon","year":"2007","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.gendis.2021.02.009_bib52","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00439-010-0805-8","article-title":"Analysis of the indel at the ARMS2 3'UTR in age-related macular degeneration","volume":"127","author":"Wang","year":"2010","journal-title":"Hum Genet"},{"issue":"5801","key":"10.1016\/j.gendis.2021.02.009_bib53","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1126\/science.1133811","article-title":"A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration","volume":"314","author":"Yang","year":"2006","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.gendis.2021.02.009_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000836","article-title":"Genetic and functional dissection of HTRA1 and LOC387715 in age-related macular degeneration","volume":"6","author":"Yang","year":"2010","journal-title":"PLoS Genet"},{"issue":"2","key":"10.1016\/j.gendis.2021.02.009_bib55","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1194\/jlr.M300306-JLR200","article-title":"Regulated expression of apolipoprotein E by human retinal pigment epithelial cells","volume":"45","author":"Ishida","year":"2004","journal-title":"J Lipid Res"},{"issue":"6","key":"10.1016\/j.gendis.2021.02.009_bib56","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0002-9394(00)00961-2","article-title":"Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation","volume":"131","author":"Anderson","year":"2001","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.gendis.2021.02.009_bib57","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1167\/iovs.05-1446","article-title":"Apolipoprotein localization in isolated drusen and retinal apolipoprotein gene expression","volume":"47","author":"Li","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.gendis.2021.02.009_bib58","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.atherosclerosis.2005.12.012","article-title":"Apolipoprotein E genotype and statins affect CRP levels through independent and different mechanisms: AGES-Reykjavik Study","volume":"186","author":"Eiriksdottir","year":"2006","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.gendis.2021.02.009_bib59","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1093\/hmg\/ddq129","article-title":"Transcriptome analysis and molecular signature of human retinal pigment epithelium","volume":"19","author":"Strunnikova","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.gendis.2021.02.009_bib60","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1167\/iovs.14-15733","article-title":"Sorsby fundus dystrophy: novel mutations, novel phenotypic characteristics, and treatment outcomes","volume":"56","author":"Gliem","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"16","key":"10.1016\/j.gendis.2021.02.009_bib61","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.1073\/pnas.0912019107","article-title":"Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC)","volume":"107","author":"Neale","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.gendis.2021.02.009_bib62","first-page":"1319","article-title":"Intraretinal lipid transport is dependent on high density lipoprotein-like particles and class B scavenger receptors","volume":"12","author":"Tserentsoodol","year":"2006","journal-title":"Mol Vis"},{"issue":"9652","key":"10.1016\/j.gendis.2021.02.009_bib63","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0140-6736(08)61348-3","article-title":"Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study","volume":"372","author":"Ennis","year":"2008","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.gendis.2021.02.009_bib64","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/ng.3546","article-title":"A missense variant in FGD6 confers increased risk of polypoidal choroidal vasculopathy","volume":"48","author":"Huang","year":"2016","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.gendis.2021.02.009_bib65","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1172\/JCI111760","article-title":"Cigarette smoke can activate the alternative pathway of complement in\u00a0vitro by modifying the third component of complement","volume":"75","author":"Kew","year":"1985","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.gendis.2021.02.009_bib66","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00251-004-0660-7","article-title":"Genetic and environmental factors influencing the human factor H plasma levels","volume":"56","author":"Esparza-Gordillo","year":"2004","journal-title":"Immunogenetics"},{"issue":"1","key":"10.1016\/j.gendis.2021.02.009_bib67","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archopht.125.1.49","article-title":"Cigarette smoking, CFH, APOE, ELOVL4, and risk of neovascular age-related macular degeneration","volume":"125","author":"DeAngelis","year":"2007","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.gendis.2021.02.009_bib68","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/archopht.125.1.55","article-title":"A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors","volume":"125","author":"Schaumberg","year":"2007","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.gendis.2021.02.009_bib69","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ophtha.2006.08.054","article-title":"Independent effects of complement factor H Y402H polymorphism and cigarette smoking on risk of age-related macular degeneration","volume":"114","author":"Scott","year":"2007","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.gendis.2021.02.009_bib70","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000094141","article-title":"CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration","volume":"61","author":"Seddon","year":"2006","journal-title":"Hum Hered"},{"key":"10.1016\/j.gendis.2021.02.009_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2013.12.004","article-title":"Nature and nurture- genes and environment- predict onset and progression of macular degeneration","volume":"40","author":"Sobrin","year":"2014","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"10.1016\/j.gendis.2021.02.009_bib72","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/aje\/kwn358","article-title":"Combined effects of complement factor H genotypes, fish consumption, and inflammatory markers on long-term risk for age-related macular degeneration in a cohort","volume":"169","author":"Wang","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.gendis.2021.02.009_bib73","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archophthalmol.2011.141","article-title":"Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and omega-3 fatty acids: the Rotterdam study","volume":"129","author":"Ho","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.gendis.2021.02.009_bib74","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ophtha.2013.10.017","article-title":"Genetic susceptibility, dietary antioxidants, and long-term incidence of age-related macular degeneration in two populations","volume":"121","author":"Wang","year":"2014","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.gendis.2021.02.009_bib75","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.ophtha.2009.11.020","article-title":"C-reactive protein and CFH, ARMS2\/HTRA1 gene variants are independently associated with risk of macular degeneration","volume":"117","author":"Seddon","year":"2010","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.gendis.2021.02.009_bib76","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/ahg.12011","article-title":"Genetic factors in nonsmokers with age-related macular degeneration revealed through genome-wide gene-environment interaction analysis","volume":"77","author":"Naj","year":"2013","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.gendis.2021.02.009_bib77","first-page":"941","article-title":"Joint effects of smoking history and APOE genotypes in age-related macular degeneration","volume":"11","author":"Schmidt","year":"2005","journal-title":"Mol Vis"},{"key":"10.1016\/j.gendis.2021.02.009_bib78","first-page":"287","article-title":"Association of the apolipoprotein E gene with age-related macular degeneration: possible effect modification by family history, age, and gender","volume":"6","author":"Schmidt","year":"2000","journal-title":"Mol Vis"},{"issue":"10","key":"10.1016\/j.gendis.2021.02.009_bib79","first-page":"3312","article-title":"Age-related changes in human RPE cell density and apoptosis proportion in situ","volume":"43","author":"Del Priore","year":"2002"},{"issue":"5","key":"10.1016\/j.gendis.2021.02.009_bib80","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1136\/bjo.85.5.510","article-title":"Evolving pathophysiological paradigms for age related macular degeneration","volume":"85","author":"Ciulla","year":"2001","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.gendis.2021.02.009_bib81","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/path.4266","article-title":"Mechanisms of age-related macular degeneration and therapeutic opportunities","volume":"232","author":"van Lookeren Campagne","year":"2014","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.gendis.2021.02.009_bib82","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0039-6257(00)00140-5","article-title":"The role of oxidative stress in the pathogenesis of age-related macular degeneration","volume":"45","author":"Beatty","year":"2000","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.gendis.2021.02.009_bib83","article-title":"Oxidation and age-related macular degeneration: insights from molecular biology","volume":"12","author":"Khandhadia","year":"2010","journal-title":"Expet Rev Mol Med"},{"issue":"2","key":"10.1016\/j.gendis.2021.02.009_bib84","first-page":"195","article-title":"Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells","volume":"25","author":"Feeney-Burns","year":"1984","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.gendis.2021.02.009_bib85","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.survophthal.2008.10.004","article-title":"Fundus autofluorescence and progression of age-related macular degeneration","volume":"54","author":"Schmitz-Valckenberg","year":"2009","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.gendis.2021.02.009_bib86","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/bjophthalmol-2012-302281","article-title":"Is sunlight exposure a risk factor for age-related macular degeneration? A systematic review and meta-analysis","volume":"97","author":"Sui","year":"2013","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.gendis.2021.02.009_bib87","first-page":"533","article-title":"Risk factors for the incidence of advanced age-related macular degeneration in the age-related eye disease study (AREDS) AREDS report no. 19","volume":"112","author":"Clemons","year":"2004","journal-title":"Ophthalmology"},{"issue":"PtB","key":"10.1016\/j.gendis.2021.02.009_bib88","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.arr.2015.09.002","article-title":"RPE necroptosis in response to oxidative stress and in AMD","volume":"24","author":"Hanus","year":"2015","journal-title":"Ageing Res Rev"},{"issue":"6","key":"10.1016\/j.gendis.2021.02.009_bib89","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1089\/rej.2011.1220","article-title":"5'-Adenosine monophosphate-activated protein kinase--mammalian target of rapamycin axis as therapeutic target for age-related macular degeneration","volume":"14","author":"Hyttinen","year":"2011","journal-title":"Rejuvenation Res"},{"key":"10.1016\/j.gendis.2021.02.009_bib90","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.arr.2017.03.006","article-title":"DNA damage response and autophagy in the degeneration of retinal pigment epithelial cells-implications for age-related macular degeneration (AMD)","volume":"36","author":"Hyttinen","year":"2017","journal-title":"Ageing Res Rev"},{"issue":"10","key":"10.1016\/j.gendis.2021.02.009_bib91","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3390\/nu8100663","article-title":"The association between the lipids levels in blood and risk of age-related macular degeneration","volume":"8","author":"Wang","year":"2016","journal-title":"Nutrients"},{"issue":"28","key":"10.1016\/j.gendis.2021.02.009_bib92","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1016\/S0042-6989(03)00475-9","article-title":"A2E, a byproduct of the visual cycle","volume":"43","author":"Sparrow","year":"2003","journal-title":"Vis Res"},{"issue":"44","key":"10.1016\/j.gendis.2021.02.009_bib93","doi-asserted-by":"crossref","first-page":"16182","DOI":"10.1073\/pnas.0604255103","article-title":"Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium","volume":"103","author":"Zhou","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.gendis.2021.02.009_bib94","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/jama.291.6.704","article-title":"Association between C-reactive protein and age-related macular degeneration","volume":"291","author":"Seddon","year":"2004","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.gendis.2021.02.009_bib95","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.4049\/jimmunol.1002488","article-title":"Complement regulation at necrotic cell lesions is impaired by the age-related macular degeneration-associated factor-H His402 risk variant","volume":"187","author":"Lauer","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.gendis.2021.02.009_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01778","article-title":"Bruch\u2019s membrane compartmentalizes complement regulation in the eye with implications for therapeutic design in age-related macular degeneration","volume":"8","author":"Clark","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.gendis.2021.02.009_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01007","article-title":"The challenges and promise of complement therapeutics for ocular diseases","volume":"10","author":"Park","year":"2019","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.gendis.2021.02.009_bib98","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.immuni.2017.01.006","article-title":"Complement factor H inhibits CD47-mediated resolution of inflammation","volume":"46","author":"Calippe","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.gendis.2021.02.009_bib99","first-page":"34","article-title":"The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration","volume":"5","author":"Campochiaro","year":"1999","journal-title":"Mol Vis"},{"issue":"5","key":"10.1016\/j.gendis.2021.02.009_bib100","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/bjo.85.5.531","article-title":"Pulsatile ocular blood flow study: decreases in exudative age-related macular degeneration","volume":"85","author":"Mori","year":"2001","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.gendis.2021.02.009_bib101","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0161-6420(95)30974-8","article-title":"Ocular blood flow velocity in age-related macular degeneration","volume":"102","author":"Friedman","year":"1995","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.gendis.2021.02.009_bib102","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0161-6420(89)32936-8","article-title":"Increased scleral rigidity and age-related macular degeneration","volume":"96","author":"Friedman","year":"1989","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.gendis.2021.02.009_bib103","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00417-006-0445-9","article-title":"Age-related macular degeneration","volume":"245","author":"Tufail","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"14","key":"10.1016\/j.gendis.2021.02.009_bib104","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1167\/iovs.13-12757","article-title":"Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging","volume":"54","author":"Bowes Rickman","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.gendis.2021.02.009_bib105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.preteyeres.2015.09.002","article-title":"Defects in retinal pigment epithelial cell proteolysis and the pathology associated with age-related macular degeneration","volume":"51","author":"Ferrington","year":"2016","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"10.1016\/j.gendis.2021.02.009_bib106","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.453","article-title":"Dysfunctional autophagy in RPE, a contributing factor in age-related macular degeneration","volume":"8","author":"Golestaneh","year":"2017","journal-title":"Cell Death Dis"},{"issue":"5","key":"10.1016\/j.gendis.2021.02.009_bib107","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0002-9394(14)70906-7","article-title":"A hemodynamic model of the pathogenesis of age-related macular degeneration","volume":"124","author":"Friedman","year":"1997","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.gendis.2021.02.009_bib108","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.molmed.2016.06.009","article-title":"Revised hemodynamic theory of age-related macular degeneration","volume":"22","author":"Gelfand","year":"2016","journal-title":"Trends Mol Med"},{"issue":"1","key":"10.1016\/j.gendis.2021.02.009_bib109","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2337\/db12-0172","article-title":"Per2 mutation recapitulates the vascular phenotype of diabetes in the retina and bone marrow","volume":"62","author":"Bhatwadekar","year":"2013","journal-title":"Diabetes"},{"issue":"13","key":"10.1016\/j.gendis.2021.02.009_bib110","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1084\/jem.20090889","article-title":"Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock","volume":"206","author":"Busik","year":"2009","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.gendis.2021.02.009_bib111","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.survophthal.2017.05.007","article-title":"The use of microperimetry in assessing visual function in age-related macular degeneration","volume":"63","author":"Cassels","year":"2018","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.gendis.2021.02.009_bib112","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/eye.2016.227","article-title":"A view of the current and future role of optical coherence tomography in the management of age-related macular degeneration","volume":"31","author":"Schmidt-Erfurth","year":"2017","journal-title":"Eye"},{"issue":"3","key":"10.1016\/j.gendis.2021.02.009_bib113","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ophtha.2008.10.006","article-title":"Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in\u00a0vivo with spectral-domain optical coherence tomography","volume":"116","author":"Schuman","year":"2009","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.gendis.2021.02.009_bib114","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ajo.2011.03.008","article-title":"Analysis of choroidal thickness in age-related macular degeneration using spectral-domain optical coherence tomography","volume":"152","author":"Manjunath","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.gendis.2021.02.009_bib115","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.survophthal.2017.06.005","article-title":"Optical coherence tomography angiography in dry age-related macular degeneration","volume":"63","author":"Cicinelli","year":"2018","journal-title":"Surv Ophthalmol"},{"issue":"8","key":"10.1016\/j.gendis.2021.02.009_bib116","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1167\/iovs.09-4968","article-title":"Choroidal blood flow and progression of age-related macular degeneration in the fellow eye in patients with unilateral choroidal neovascularization","volume":"51","author":"Boltz","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.gendis.2021.02.009_bib117","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/archopht.126.5.670","article-title":"Reduction of endogenous angiogenesis inhibitors in Bruch's membrane of the submacular region in eyes with age-related macular degeneration","volume":"126","author":"Bhutto","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.gendis.2021.02.009_bib118","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/IAE.0000000000002452","article-title":"Swept-source and spectral domain optical coherence tomography angiography versus dye angiography in the measurement of type 1 neovascularization","volume":"40","author":"Cicinelli","year":"2019","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.gendis.2021.02.009_bib119","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3928\/23258160-20141118-03","article-title":"Ultrahigh-speed swept-source OCT angiography in exudative AMD","volume":"45","author":"Moult","year":"2014","journal-title":"Ophthalmic Surg Lasers Imag Ret"},{"issue":"7","key":"10.1016\/j.gendis.2021.02.009_bib120","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.ophtha.2014.01.034","article-title":"Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration","volume":"121","author":"Jia","year":"2014","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.gendis.2021.02.009_bib121","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1097\/IAE.0000000000002228","article-title":"Improved detection and diagnosis of polypoidal choroidal vasculopathy using a combination of optical coherence tomography and optical coherence tomography angiography","volume":"39","author":"Cheung","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.gendis.2021.02.009_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1179172116686075","article-title":"Optical coherence tomographic angiography imaging in age-related macular degeneration","volume":"9","author":"Ma","year":"2017","journal-title":"Ophthalmol Eye Dis"},{"issue":"5","key":"10.1016\/j.gendis.2021.02.009_bib123","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.cell.2018.02.010","article-title":"Identifying medical diagnoses and treatable diseases by image-based deep learning","volume":"172","author":"Kermany","year":"2018","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.gendis.2021.02.009_bib124","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00417-017-3850-3","article-title":"Automated detection ofexudative age-related macular degeneration in spectral domain op-tical coherence tomography using deep learning","volume":"256","author":"Treder","year":"2018","journal-title":"Graefe ArchClin Exp"},{"issue":"10","key":"10.1016\/j.gendis.2021.02.009_bib125","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/S0161-6420(99)90400-1","article-title":"Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration","volume":"106","author":"Reichel","year":"1999","journal-title":"Ophthalmology"},{"issue":"10\u201312","key":"10.1016\/j.gendis.2021.02.009_bib126","first-page":"289","article-title":"Transpupillary thermotherapy (TTT) with injections of triamcinolone acetonide under posterior Tenon's capsule in the treatment of exudative age-related macular degeneration (AMD)","volume":"112","author":"Agnieszka","year":"2010","journal-title":"Klin Oczna"},{"issue":"5","key":"10.1016\/j.gendis.2021.02.009_bib127","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/bjophthalmol-2011-300721","article-title":"Combination therapy with low-dose transpupillary thermotherapy and intravitreal ranibizumab for neovascular age-related macular degeneration: a 24-month prospective randomised clinical study","volume":"96","author":"S\u00f6derberg","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.gendis.2021.02.009_bib128","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ajo.2010.07.021","article-title":"Photodynamic therapy for polypoidal choroidal vasculopathy","volume":"150","author":"Kumar Chhablani","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.gendis.2021.02.009_bib129","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2165\/00003495-200868080-00002","article-title":"Neovascular age-related macular degeneration: potential therapies","volume":"68","author":"Chappelow","year":"2008","journal-title":"Drugs"},{"issue":"9597","key":"10.1016\/j.gendis.2021.02.009_bib130","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(07)61627-4","article-title":"New treatments for age-related macular degeneration","volume":"370","author":"Hamilton","year":"2007","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.gendis.2021.02.009_bib131","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.gendis.2021.02.009_bib132","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus verteporfin for neovascular age-related macular degeneration","volume":"355","author":"Brown","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.gendis.2021.02.009_bib133","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajo.2011.11.022","article-title":"Changing trends of blindness: the initial harvest from translational public health and clinical research in ophthalmology","volume":"153","author":"Cheung","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.gendis.2021.02.009_bib134","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1167\/iovs.18-24522","article-title":"Reduced vessel density of the choriocapillaris during anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration","volume":"60","author":"Hikichi","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.gendis.2021.02.009_bib135","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrd1955","article-title":"Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease","volume":"5","author":"Ng","year":"2006","journal-title":"Nat Rev Drug Discov"},{"issue":"27","key":"10.1016\/j.gendis.2021.02.009_bib136","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"VEGF inhibition study in ocular neovascularization clinical trial group. Pegaptanib for neovascular age-related macular degeneration","volume":"351","author":"Gragoudas","year":"2004","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.gendis.2021.02.009_bib137","doi-asserted-by":"crossref","first-page":"11393","DOI":"10.1073\/pnas.172398299","article-title":"VEGF-Trap: a VEGF blocker with potent antitumor effects","volume":"99","author":"Holash","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.gendis.2021.02.009_bib138","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.gendis.2021.02.009_bib139","first-page":"37","article-title":"Recombinant anti-vascular endothelial growth factor fusion protein efficiently suppresses choridal neovasularization in monkeys","volume":"14","author":"Zhang","year":"2008","journal-title":"Mol Vis"},{"issue":"1","key":"10.1016\/j.gendis.2021.02.009_bib140","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s11095-008-9718-9","article-title":"The pharmacology study of a new recombinant human VEGF receptor-fc fusion protein on experimental choroidal neovascularization","volume":"26","author":"Zhang","year":"2009","journal-title":"Pharmaceut Res"},{"issue":"9","key":"10.1016\/j.gendis.2021.02.009_bib141","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.ophtha.2014.03.026","article-title":"Safety and efficacy of conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study: AURORA study","volume":"121","author":"Li","year":"2014","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.gendis.2021.02.009_bib142","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ophtha.2019.04.017","article-title":"HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration","volume":"127","author":"Dugel","year":"2020","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.gendis.2021.02.009_bib143","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/jamaophthalmol.2020.2699","article-title":"Efficacy of every four monthly and quarterly dosing of faricimab vs ranibizumab in neovascular age-related macular degeneration the STAIRWAY phase 2 randomized clinical tria","volume":"138","author":"Khanani","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.gendis.2021.02.009_bib144","first-page":"e10","article-title":"Evaluation of abicipar pegol (ananti-VEGF DARPIN therapeutic) in patients with neovascular age-relatedmacular degeneration: studies in Japan and the United States","volume":"50","author":"Kunimoto","year":"2019","journal-title":"Ophthal Surg Lasers Imag Ret"},{"issue":"10","key":"10.1016\/j.gendis.2021.02.009_bib145","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archopht.119.10.1439","article-title":"A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9","volume":"119","author":"Age-Related Eye Disease Study Research Group","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"10.1016\/j.gendis.2021.02.009_bib146","first-page":"1309","article-title":"Growth characteristics and ultrastructure of human retinal pigment epithelium in\u00a0vitro","volume":"19","author":"Flood","year":"1980","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.gendis.2021.02.009_bib147","first-page":"101","article-title":"Human retinal pigment epithelial cells in tissue culture: a means of studying inherited retinal diseases","volume":"18","author":"Boulton","year":"1982","journal-title":"Birth Defects Orig Artic Ser"},{"issue":"6","key":"10.1016\/j.gendis.2021.02.009_bib148","first-page":"67","article-title":"Morphology, phagocytosis, and vitamin A metabolism of cultured human retinal pigment epithelium","volume":"18","author":"Hu","year":"1982","journal-title":"Birth Defects Orig Artic Ser"},{"issue":"10","key":"10.1016\/j.gendis.2021.02.009_bib149","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1136\/bjo.2009.172593","article-title":"Long-term outcomes following full macular translocation surgery in neovascular age-related macular degeneration","volume":"94","author":"Chen","year":"2010","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.gendis.2021.02.009_bib150","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/archopht.121.1.132","article-title":"Macular translocation with 360 degrees peripheral retinectomy for geographic atrophy","volume":"121","author":"Cahill","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.gendis.2021.02.009_bib151","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.biomaterials.2008.09.039","article-title":"The in\u00a0vitro and in\u00a0vivo behaviour of retinal pigment epithelial cells cultured on ultrathin collagen membranes","volume":"30","author":"Thumann","year":"2009","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.gendis.2021.02.009_bib152","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1167\/iovs.11-8260","article-title":"Subretinal delivery of ultrathin rigid-elastic cell carriers using a metallic shooter instrument and biodegradable hydrogel encapsulation","volume":"53","author":"Stanzel","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.gendis.2021.02.009_bib153","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s00417-003-0764-z","article-title":"Translocation of iris pigment epithelium in patients with exudative age-related macular degeneration: long-term results","volume":"242","author":"Lappas","year":"2004","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.gendis.2021.02.009_bib154","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0014-4835(88)90073-5","article-title":"Inherited retinal dystrophy in the RCS rat: prevention of photoreceptor degeneration by pigment epithelial cell transplantation","volume":"47","author":"Li","year":"1988","journal-title":"Exp Eye Res"},{"issue":"7","key":"10.1016\/j.gendis.2021.02.009_bib155","first-page":"1131","article-title":"Transplantation of cultured rabbit retinal epithelium to rabbit retina using a closed-eye method","volume":"28","author":"Lopez","year":"1987","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"24","key":"10.1016\/j.gendis.2021.02.009_bib156","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1016\/S0042-6989(96)00180-0","article-title":"Retinal cell transplantation in the macula: new techniques","volume":"36","author":"Gouras","year":"1996","journal-title":"Vis Res"},{"issue":"8","key":"10.1016\/j.gendis.2021.02.009_bib157","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/eye.2015.89","article-title":"Retinal pigment epithelium transplantation: concepts, challenges, and future prospects","volume":"29","author":"Alexander","year":"2015","journal-title":"Eye"},{"issue":"1\u20132","key":"10.1016\/j.gendis.2021.02.009_bib158","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1055\/s-2002-23501","article-title":"Cyclotropia and surgical treatment after macular translocation","volume":"219","author":"Akyurt","year":"2002","journal-title":"Klin Monbl Augenheilkd"},{"issue":"5","key":"10.1016\/j.gendis.2021.02.009_bib159","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0002-9394(98)00020-8","article-title":"Macular translocation","volume":"125","author":"Machemer","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.gendis.2021.02.009_bib160","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/bjo.2009.170381","article-title":"Macular translocation with 360-degree retinotomy f or management of retinal pigment epithelial tear: long-term results","volume":"95","author":"Polito","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"9817","key":"10.1016\/j.gendis.2021.02.009_bib161","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(12)60028-2","article-title":"Embryonic stem cell trials for macular degeneration: a preliminary report","volume":"379","author":"Schwartz","year":"2012","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.gendis.2021.02.009_bib162","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nbt.4114","article-title":"Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration","volume":"36","author":"Da Cruz","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"11","key":"10.1016\/j.gendis.2021.02.009_bib163","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","article-title":"Autologous induced stem-cell-derived retinal cells for macular degeneration","volume":"376","author":"Mandai","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gendis.2021.02.009_bib164","first-page":"1","article-title":"Novel stem cell and gene therapy in diabetic retinopathy, age related macular degeneration, and retinitis pigmentosa","volume":"5","author":"Ludwig","year":"2019","journal-title":"Int J Ret Vitr"},{"issue":"1","key":"10.1016\/j.gendis.2021.02.009_bib165","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/gt.2008.115","article-title":"Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization","volume":"16","author":"Pechan","year":"2009","journal-title":"Gene Ther"},{"key":"10.1016\/j.gendis.2021.02.009_bib166","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ebiom.2016.11.016","article-title":"Phase 2a randomized clinical trial: safety and post hoc analysis of subretinal rAAV.sFLT-1 for wet age-related macular degeneration","volume":"14","author":"Constable","year":"2016","journal-title":"EBioMedicine"},{"issue":"10089","key":"10.1016\/j.gendis.2021.02.009_bib167","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(17)30979-0","article-title":"Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial","volume":"390","author":"Heier","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.gendis.2021.02.009_bib168","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1089\/hum.2009.153","article-title":"Adeno-associated vector (type 8)-mediated expression of soluble Flt-1 efficiently inhibits neovascularization in a murine choroidal neovascularization model","volume":"21","author":"Igarashi","year":"2010","journal-title":"Hum Gene Ther"},{"issue":"2","key":"10.1016\/j.gendis.2021.02.009_bib169","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/mt.2010.258","article-title":"Preclinical safety evaluation of AAV2-sFLT01- a gene therapy for age-related macular degeneration","volume":"19","author":"Maclachlan","year":"2011","journal-title":"Mol Ther"},{"issue":"10011","key":"10.1016\/j.gendis.2021.02.009_bib170","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/S0140-6736(15)00345-1","article-title":"Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: one year follow-up of a phase 1 randomised clinical trial","volume":"386","author":"Rakoczy","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gendis.2021.02.009_bib171","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)61697-5","article-title":"Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin","volume":"159","author":"Mori","year":"2001","journal-title":"Am J Pathol"},{"issue":"13","key":"10.1016\/j.gendis.2021.02.009_bib172","doi-asserted-by":"crossref","first-page":"8909","DOI":"10.1073\/pnas.122247299","article-title":"Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization","volume":"99","author":"Raisler","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.gendis.2021.02.009_bib173","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11373-007-9153-7","article-title":"Inhibition of corneal neovascularization with endostatin delivered by adeno-associated viral (AAV) vector in a mouse corneal injury model","volume":"14","author":"Lai","year":"2007","journal-title":"J Biomed Sci"},{"issue":"2","key":"10.1016\/j.gendis.2021.02.009_bib174","first-page":"97","article-title":"Transposon-based, targeted ex\u00a0vivo gene therapy to treat age-related macular degeneration (target AMD). Human gene therapy","volume":"26","author":"Thumann","year":"2015","journal-title":"Clin Develop"},{"key":"10.1016\/j.gendis.2021.02.009_bib175","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.2147\/DDDT.S115801","article-title":"Preliminary in\u00a0vitro and in\u00a0vivo assessment of a new targeted inhibitor for choroidal neovascularization in age-related macular degeneration","volume":"10","author":"Li","year":"2016","journal-title":"Drug Des Dev Ther"},{"issue":"12","key":"10.1016\/j.gendis.2021.02.009_bib176","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1136\/bjo.2010.186361","article-title":"Cytokines in neovascular age-related macular degeneration: fundamentals of targeted combination therapy","volume":"95","author":"De Oliveira Dias","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"16","key":"10.1016\/j.gendis.2021.02.009_bib177","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2012.4091","article-title":"Age-related macular degeneration","volume":"308","author":"Goodman","year":"2012","journal-title":"JAMA"},{"issue":"5S","key":"10.1016\/j.gendis.2021.02.009_bib178","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.ophtha.2013.01.061","article-title":"Emerging therapies for neovascular age-related macular degeneration: drugs in the pipeline","volume":"120","author":"Kaiser","year":"2013","journal-title":"Ophthalmology"}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304221000295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304221000295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:28:44Z","timestamp":1762450124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304221000295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":178,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2352304221000295"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2021.02.009","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age-related macular degeneration: Epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2021.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Chongqing Medical University. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}